These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 7309892)

  • 1. Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
    Bower L; Manley G
    J Clin Pathol; 1981 Oct; 34(10):1097-101. PubMed ID: 7309892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of glycosaminoglycans in disseminated neoplasm.
    Manley G; Bower L; Anson A
    J Clin Pathol; 1978 May; 31(5):447-53. PubMed ID: 649771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone.
    Kelleher PC
    Clin Chim Acta; 1979 Mar; 92(3):373-9. PubMed ID: 436278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An electrophoretic fraction of urinary glycosaminoglycans reflecting connective tissue turnover.
    Poulsen JH
    Scand J Clin Lab Invest; 1981 Nov; 41(7):675-81. PubMed ID: 7339868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?
    Hamdy NA; Papapoulos SE; Colwell A; Eastell R; Russell RG
    Bone Miner; 1993 Jul; 22(1):1-8. PubMed ID: 8219934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excretion patterns of glycosaminoglycans and glycoproteins in normal human urine.
    Manley G; Severn M; Hawksworth J
    J Clin Pathol; 1968 May; 21(3):339-45. PubMed ID: 4235293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chromatographic analysis of urinary amino acids in Paget's disease. II : clinical study].
    Roques CF; Mazières B; Amigues H; Fournie A; Arlet J; Ruffié R
    Rev Rhum Mal Osteoartic; 1976 Apr; 43(4):255-8. PubMed ID: 1273475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of glycosaminoglycans in the various forms of gargoylism.
    Manley G; Williams U
    J Clin Pathol; 1969 Jan; 22(1):67-75. PubMed ID: 4239429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactosyl hydroxylysine in assessment of Paget's bone disease.
    Michalsky M; Stepan JJ; Wilczek H; Formankova J; Moro L
    Clin Chim Acta; 1995 Jan; 234(1-2):101-8. PubMed ID: 7758208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.
    Torres R; de la Piedra C; Rapado A
    Calcif Tissue Int; 1991 Jul; 49(1):14-6. PubMed ID: 1893290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P; Gineyts E; Riou JP; Delmas PD
    J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPC precipitable uronic acid: creatinine ratio in random urine samples collected from normal children.
    Pennock CA; White F; Wharton BA
    Acta Paediatr Scand; 1972 Mar; 61(2):125-7. PubMed ID: 4258717
    [No Abstract]   [Full Text] [Related]  

  • 15. A column chromatography fractionation of the hydroxyproline-containing urinary peptides with continuous automatic detection.
    Szymanowicz A; Malgras A; Cosson R; Randoux A; Borel JP
    Ann Biol Clin (Paris); 1975; 33(5):351-8. PubMed ID: 1217759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen-like fragments: excretion in urine of patients with Paget's disease of bone.
    Krane SM; Muñoz AJ; Harris ED
    Science; 1967 Aug; 157(3789):713-6. PubMed ID: 6028049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone. A double-blind, multiple-dosage, placebo-controlled study.
    Reginster JY; Colson F; Morlock G; Combe B; Ethgen D; Geusens P
    Arthritis Rheum; 1992 Aug; 35(8):967-74. PubMed ID: 1642662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary polypeptides related to collagen synthesis.
    Krane SM; Muñoz AJ; Harris ED
    J Clin Invest; 1970 Apr; 49(4):716-29. PubMed ID: 4315304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
    Papapoulos SE; Frölich M
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hydroxyproline excretion in the urine in Paget's osteodystrophia deformans. Comparative clinical, morphological and biochemical studies].
    Raab W; Czitober H
    Wien Klin Wochenschr; 1967 Feb; 79(5):91-3. PubMed ID: 5591364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.